Skip to main content
. 2016 Sep 29;215(1):24–33. doi: 10.1093/infdis/jiw453

Figure 3.

Figure 3.

Geometric mean concentrations (GMCs) of anti–respiratory syncytial virus prefusion (RSV-PreF) antibodies before vaccination and on days 30, 60, 180, and 360 after vaccination, by study vaccine group—adapted according-to-protocol (ATP) cohort for immunogenicity. The adapted ATP cohort is as follows: the analysis on the time points up to day 60 comprised the ATP cohort for immunogenicity (n = 119), and the analysis on day 180 and day 360 comprised the ATP cohort for persistence (n = 114). Saccharose NaCl served as the control. Error bars depict 95% confidence intervals (CIs).